| P50 | author | Ken Mackie | Q37831452 |
| P2093 | author name string | Sherry Shu-Jung Hu | |
| P2860 | cites work | Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. | Q44334367 |
| | Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism | Q44346123 |
| | Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment | Q44350109 |
| | Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord | Q44351566 |
| | Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia | Q44451116 |
| | Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling | Q44455990 |
| | Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets | Q44468853 |
| | Neuromorphological background of cannabis addiction | Q44494962 |
| | Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia | Q44896145 |
| | Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling | Q44898857 |
| | Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Q44963304 |
| | Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles | Q44970457 |
| | RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol | Q44991723 |
| | Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington's disease brain. | Q45299988 |
| | How reliable are G-protein-coupled receptor antibodies? | Q45352520 |
| | Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei | Q46368889 |
| | Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. | Q46384445 |
| | N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation | Q46487797 |
| | GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons | Q46566097 |
| | Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain | Q46578549 |
| | Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain | Q46772666 |
| | Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans | Q47694056 |
| | Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. | Q48028956 |
| | Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation | Q48120764 |
| | Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro | Q48127886 |
| | Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus | Q48173430 |
| | Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors | Q48193422 |
| | Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. | Q48217036 |
| | Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice | Q48229623 |
| | Calcium dependence of retrograde inhibition by endocannabinoids at synapses onto Purkinje cells. | Q48251433 |
| | Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain | Q24299523 |
| | Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 |
| | Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase | Q24555807 |
| | The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors | Q24617322 |
| | A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol | Q24649418 |
| | Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons | Q28144567 |
| | Role of endogenous cannabinoids in synaptic signaling | Q28185075 |
| | Molecular characterization of a phospholipase D generating anandamide and its congeners | Q28186509 |
| | CB1 cannabinoid receptors and on-demand defense against excitotoxicity | Q28207143 |
| | Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells | Q28212245 |
| | Structure of a cannabinoid receptor and functional expression of the cloned cDNA | Q28240076 |
| | CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a | Q28250631 |
| | Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types | Q28262858 |
| | The endocannabinoid system drives neural progenitor proliferation | Q28263148 |
| | Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro | Q28345158 |
| | The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum | Q28587112 |
| | Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice | Q28591248 |
| | Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 |
| | Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 |
| | Mechanisms underlying input-specific expression of endocannabinoid-mediated synaptic plasticity in the dorsal cochlear nucleus | Q30464098 |
| | Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem | Q30481732 |
| | Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala | Q30498563 |
| | Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. | Q31813503 |
| | The functional neuroanatomy of brain cannabinoid receptors | Q48285221 |
| | Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. | Q48291065 |
| | Cannabinoids reveal importance of spike timing coordination in hippocampal function | Q48364611 |
| | Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. | Q48446203 |
| | Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. | Q48556515 |
| | Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum | Q48581988 |
| | Mitochondrial CB₁ receptors regulate neuronal energy metabolism | Q48629492 |
| | Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis | Q48655780 |
| | Fatty acid amide hydrolase expression in rat choroid plexus: possible role in regulation of the sleep-inducing action of oleamide | Q48728362 |
| | Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat. | Q48786464 |
| | Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. | Q51985298 |
| | Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. | Q52030475 |
| | An open letter to our readers on the use of antibodies | Q56038598 |
| | Cannabinoid CB1 Receptor Expression in Rat Spinal Cord | Q56827591 |
| | Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist | Q57990422 |
| | CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons | Q60155175 |
| | Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry | Q64212082 |
| | A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain | Q64212085 |
| | Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina | Q73129294 |
| | Antibodies as valuable neuroscience research tools versus reagents of mass distraction | Q80050544 |
| | CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum | Q31817073 |
| | Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse | Q31900735 |
| | Pain modulation by release of the endogenous cannabinoid anandamide | Q33421146 |
| | Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. | Q33716248 |
| | Motor actions of cannabinoids in the basal ganglia output nuclei | Q33720160 |
| | Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor. | Q33765631 |
| | Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. | Q33918606 |
| | CB2: a cannabinoid receptor with an identity crisis | Q34098185 |
| | Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo | Q34160453 |
| | Benefits and pitfalls of secondary antibodies: why choosing the right secondary is of primary importance | Q34295826 |
| | Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals | Q34305700 |
| | Architecture of cannabinoid signaling in mouse retina | Q34313968 |
| | Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase | Q34385277 |
| | An endocannabinoid mechanism for stress-induced analgesia. | Q34428429 |
| | Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. | Q34461240 |
| | Involvement of the endocannabinoid system in drug addiction | Q34495242 |
| | Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice | Q34581274 |
| | Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus | Q34582789 |
| | Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules | Q34722804 |
| | Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study, with a note on the fiber-of-passage problem | Q34730677 |
| | Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system | Q34745063 |
| | Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors | Q35202878 |
| | Molecular composition of the endocannabinoid system at glutamatergic synapses. | Q35220762 |
| | Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain. | Q35600288 |
| | Cannabinoid action in the olfactory epithelium | Q35669839 |
| | Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors | Q35807657 |
| | CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. | Q35870490 |
| | On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures | Q35903023 |
| | Synapse type-independent degradation of the endocannabinoid 2-arachidonoylglycerol after retrograde synaptic suppression. | Q36132823 |
| | Distribution of cannabinoid receptors in the central and peripheral nervous system. | Q36441196 |
| | Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors | Q36447081 |
| | Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. | Q36452302 |
| | Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony | Q36535379 |
| | Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. | Q36612284 |
| | Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system | Q36749082 |
| | The endocannabinoid system and neurogenesis in health and disease. | Q36778571 |
| | Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus | Q36917918 |
| | The endocannabinoid system and gut-brain signalling. | Q36955435 |
| | Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. | Q37216017 |
| | Endocannabinoid signaling in microglial cells | Q37250243 |
| | Wiring and firing neuronal networks: endocannabinoids take center stage | Q37272835 |
| | Endocannabinoid-mediated control of synaptic transmission | Q37363621 |
| | Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes | Q37372853 |
| | Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria | Q37518247 |
| | Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas | Q37752096 |
| | Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses | Q38280778 |
| | Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry | Q38331458 |
| | Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord | Q39571942 |
| | Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. | Q39831177 |
| | Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. | Q40552011 |
| | Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia | Q40660673 |
| | Studying mitochondrial CB1 receptors: Yes we can. | Q40788324 |
| | Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway | Q41791622 |
| | Physiological activation of cholinergic inputs controls associative synaptic plasticity via modulation of endocannabinoid signaling | Q41985197 |
| | The endocannabinoid system controls key epileptogenic circuits in the hippocampus | Q42065383 |
| | Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain | Q42451047 |
| | Complementary distribution of type 1 cannabinoid receptors and vesicular glutamate transporter 3 in basal forebrain suggests input-specific retrograde signalling by cholinergic neurons | Q42452898 |
| | Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry | Q42471010 |
| | The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice | Q42485353 |
| | Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. | Q42488876 |
| | Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum | Q42494226 |
| | CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action | Q42498502 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Localization of cannabinoid receptor mRNA in rat brain | Q42510202 |
| | Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. | Q42513159 |
| | Self-modulation of neocortical pyramidal neurons by endocannabinoids | Q43241797 |
| | Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret | Q43770448 |
| | Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids. | Q43833741 |
| | Astrocytes in culture produce anandamide and other acylethanolamides. | Q43935534 |
| | Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. | Q43948450 |
| | What is the amygdala? | Q43987421 |
| | Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids | Q44051647 |
| | The endogenous cannabinoid system controls extinction of aversive memories | Q44085607 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoid system | Q368952 |
| P304 | page(s) | 59-93 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Handbook of experimental pharmacology | Q26841924 |
| P1476 | title | Distribution of the Endocannabinoid System in the Central Nervous System | |
| P478 | volume | 231 | |